Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis
Keywords: AE; adverse event; BCDVA; best-corrected distance visual acuity; CBA; Cochet-Bonnet aesthesiometer; CI; confidence interval; ETDRS; Early Treatment Diabetic Retinopathy Study; mNGF; murine nerve growth factor; NGF; nerve growth factor; NK; neurotrophic ke